☆ 4.3 Article

Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer

CLINICAL & EXPERIMENTAL METASTASIS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Changing characteristics, treatment approaches and survival of patients with brain metastasis: data from six thousand and thirty-one individuals over an observation period of 30 years

Ariane Steindl et al.

Summary: Patient classification is crucial for guiding individualized treatment decisions and forming brain metastases (BMs) cohorts for clinical trials. The study reveals shifting trends in the presentation and treatment strategies of BM patients over the past decades. The presence of targetable driver mutations affects the clinical presentation and prognosis, emphasizing the need to address the modern composition of BM cohorts and the distinct clinical course of patients with targetable driver mutations in future BM-specific trials.

EUROPEAN JOURNAL OF CANCER (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival

Arnaud Jannin et al.

Summary: This study aimed to evaluate the overall survival and prognostic factors of differentiated thyroid carcinoma patients with bone metastases, as well as the effectiveness of radioiodine treatment. The study found that approximately one-third of patients achieved a complete bone metastasis response following radioiodine treatment. The presence of (18)FDG uptake in bone metastases was associated with poor overall survival.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

添加到收藏夹

Review Oncology

Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era

Jaume Capdevila et al.

Summary: Most malignant thyroid tumours are initially treated with surgery or a combination of surgery and radioactive iodine therapy. However, in patients with metastatic disease, many tumours become refractory to radioactive iodine (RAI), and these patients require alternative treatments, such as locoregional therapies and/or systemic treatment with multikinase inhibitors. Targeted therapies based on genetic alterations have shown clinical efficacy in thyroid cancer, including NTRK gene fusions, RET and BRAF inhibitions. Effective testing strategies for these genetic alterations are crucial for identifying patients who could benefit from targeted treatments.

CANCER TREATMENT REVIEWS (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma

Christine Dierks et al.

Summary: The combination therapy of lenvatinib and pembrolizumab may be safe and effective in patients with ATC/PDTC, resulting in complete and long-term remissions.

THYROID (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers

Lara A. Dunn et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Thyroid Cancer Brain Metastasis Survival and Genomic Characteristics of a Large Tertiary Care Cohort

Joseph R. Osborne et al.

CLINICAL NUCLEAR MEDICINE (2019)

添加到收藏夹

Article Oncology

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

S. Filetti et al.

ANNALS OF ONCOLOGY (2019)

添加到收藏夹

Article Endocrinology & Metabolism

Brain Metastases From Differentiated Thyroid Carcinoma: Prevalence, Current Therapies, and Outcomes

Cristiane J. Gomes-Lima et al.

JOURNAL OF THE ENDOCRINE SOCIETY (2019)

添加到收藏夹

Article Oncology

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer

Vivek Subbiah et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

添加到收藏夹

Article Surgery

Outcomes and prognostic factors in thyroid cancer patients with cranial metastases: A retrospective cohort study of 4,683 patients

Yi-Wen Hong et al.

INTERNATIONAL JOURNAL OF SURGERY (2018)

添加到收藏夹

Article Oncology

Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial

L. Belin et al.

ANNALS OF ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)

Alexander Drilon et al.

CANCER DISCOVERY (2017)

添加到收藏夹

Article Endocrinology & Metabolism

Chemotherapy and tyrosine-kinase inhibitors for medullary thyroid cancer

Julien Hadoux et al.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2017)

添加到收藏夹

Article Oncology

Vemurafenib in patients with BRAFV600E-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial

Marcia S. Brose et al.

LANCET ONCOLOGY (2016)

添加到收藏夹

Article Multidisciplinary Sciences

The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups

Jinhyun Choi et al.

PLOS ONE (2016)

添加到收藏夹

Article Endocrinology & Metabolism

Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?

Ian Ganly et al.

THYROID (2015)

添加到收藏夹

Article Oncology

Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib

S. Michael Rothenberg et al.

CLINICAL CANCER RESEARCH (2015)

添加到收藏夹

Article Endocrinology & Metabolism

Brain Metastases from Thyroid Carcinoma: A Retrospective Study of 21 Patients

Benedicte Henriques de Figueiredo et al.

THYROID (2014)

添加到收藏夹

Article Oncology

Current Understanding and Management of Medullary Thyroid Cancer

Madhuchhanda Roy et al.

ONCOLOGIST (2013)

添加到收藏夹

Article Oncology

Gamma knife radiosurgery for metastatic brain tumors from thyroid cancer

In-Young Kim et al.

JOURNAL OF NEURO-ONCOLOGY (2009)

添加到收藏夹

Article Oncology

Prognosis of medullary thyroid carcinoma - Demographic, clinical, and pathologic predictors of survival in 1252 cases

Sanziana Roman et al.

CANCER (2006)

添加到收藏夹

Article Otorhinolaryngology

Distant metastases from thyroid and parathyroid cancer

AR Shaha et al.

ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES (2001)

添加到收藏夹

Article Oncology

Single brain metastasis from thyroid cancer: Report of twelve cases and review of the literature

M Salvati et al.

JOURNAL OF NEURO-ONCOLOGY (2001)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Brain metastasis from differentiated thyroid cancer in patients treated with radioiodine for bone and lung lesions

T Misaki et al.

ANNALS OF NUCLEAR MEDICINE (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.